No.1 Opportunity for 2025 [Take Action Now!]

Starlink's potential IPO Could Be the Biggest in History--Silicon Valley insider James Altucher has uncovered a way to profit BEFORE the IPO--with as little as $50. Musk's $180B giant is set to launch--will you miss out? Claim your spot before it's too late.

BMY
Bristol-Myers Squibb Co
NYSE
46.92
Open 47.21 Prev Close 47.63
High 47.26 Low 46.69
Volume 7,024,133 Volume (Avg) 15,599
52 Week High 61.84 52 Week Low 37.72
Market Cap 95.5B PE Ratio 17.62

Shares Stats

Shares Outstanding2,035,000,000
Shares Float2,032,990,000
Shares Short33,610,000
Insider Holdings7%
Institution Holdings82.11%

About Bristol-Myers Squibb Co

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

General

NameBristol-Myers Squibb Co
TickerBMY
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees34,100

Highlights

Analyst Target55.95
Market Cap95,486,000,000
PE Ratio17.62
PEG Ratio2.26
EBITDA19,174,000,640

Financials

Curr Year EPS Estimate6.76
Next Quarter EPS Estimate1.69
Profit Margin11.38%
Operating Margin22.93
Return on Assets0.07
Return on Equity0.32
Revenue47.6B
Earnings Per Share2.68
Revenue Per Share23.48
Gross Profit35,578,998,784
Quarterly Revenue Growth-0.06

Valuation

Trailing PE17.51
Forward PE6.97
Price/Sales (Trailing 12 Mt.)2.00
Price/Book (Most Recent Quarter)5.49

Dividend

Bristol-Myers Squibb Co pays out a dividend of $2.48 per share, with a dividend yield of 5.29%.

BMY's next dividend payment will be made to shareholders on August 1, 2025.

They pay out 0.00% of their earnings out as a dividend.

Recent Dividends

Dec 31, 1969$0.62
May 1, 2025$0.62
Feb 3, 2025$0.62
Nov 1, 2024$0.60
Aug 1, 2024$0.60
May 1, 2024$0.60
Feb 1, 2024$0.60
Nov 1, 2023$0.57
Aug 1, 2023$0.57
Most Popular

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

A judge resisted Trump’s order on gender identity. The EEOC just fired her

The federal agency charged with protecting workers’ civil rights has terminated a New York administrative judge who , including President Donald Trump’s executive order decreeing male and female as .

A Historic Gold Announcement Is About to Rock Wall Street - Ad

The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.

This Stock Just Popped 30% In 5 Days — Now Expert Says It 'Looks Potentially Explosive'

Experts have been betting on the growth prospects of Oscar Health, as it surged by 16.51% on Wednesday and 32.56% in the last five days.

What It's Really Like To Work With Elon... - Ad

A business partner of mine recently told me how one morning, Elon's "DOGE Agents" simply showed up. The whole departments were merged. Dozens of tasks and contracts were reassigned. Several projects were permanently shut down and replaced. That's when he called me, and I realized what was happening.

Lisa Murkowski Defends Alaska Carveouts As Elizabeth Warren, Bernie Sanders And Rand Paul Condemn Trump's 'Big Beautiful' Bill: 'Not Good Enough For The Rest Of Our Nation'

Senators across party lines are fiercely divided over Donald Trump's $3.3 trillion "Big Beautiful Bill," which narrowly passed the Senate and now heads to the House amid concerns over debt, tax cuts, and social program rollbacks.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Medicaid, food aid recipients worry about safety net cuts in bill sent to Trump

JEFFERSON CITY, Mo. (AP) — Supporters of the that Congress has sent to President Donald Trump say the changes to Medicaid, food aid and other programs will encourage personal responsibility and halt those scamming the system.

Tesla Rival Xiaomi Wants To Sell Cars Internationally Starting 2027, CEO Lei Jun Says

Xiaomi plans to sell its electric vehicles overseas as SU7 and YU7 models gather steam in the Chinese domestic market.

The Missing Ingredient for Big Tech's $3T Recipe? - Ad

Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.

Ivy League MBA Was A 'Waste Of Time,' Says Veteran Banker, Lists Two Key Traits Far More Relevant In The AI Age

Standard Chartered CEO Bill Winters says his MBA was a waste of time, and today's leaders need curiosity and empathy, not just technical skills.

Scott Bessent On Replacing Powell As Fed Chair: 'I Will Do What The President Wants' — Plays Down Shadow Chair Speculations

U.S. Treasury Secretary Scott Bessent declined to rule out the possibility of replacing Jerome Powell as Federal Reserve Chair and has instead deferred to President Donald Trump's decision on the matter.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

After Diddy's conviction, here's where his business ventures stand

LOS ANGELES (AP) — Sean “Diddy” Combs has been in his federal sex trafficking trial, but that doesn't mean the once-celebrated music mogul will see his business empire restored.

Intel (INTC) Stock Falls On Report Of Major Chip Strategy Shift

Intel shares are trading lower Wednesday afternoon. CEO Lip-Bu Tan is reportedly considering a strategic pivot away from marketing its costly 18A chipmaking process.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Apple Sues Ex-Engineer Over Alleged Theft Of Vision Pro Secrets As Snap Prepares AR Glasses Launch

Apple files lawsuit accusing former senior design engineer of stealing confidential information before leaving to work at Snap.

Supreme Court takes up a Republican appeal to end limits on party spending in federal elections

WASHINGTON (AP) — will take up a Republican-led drive, backed by President Donald Trump's administration, to wipe away limits on how much political parties can spend in coordination with candidates for Congress and president.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

US calls reported threats by pro-Iran hackers to release Trump-tied material a 'smear campaign'

WASHINGTON (AP) — Pro-Iran hackers have threatened to release emails supposedly stolen from people connected to President Donald Trump, according to a news report, a move that federal authorities call a “calculated smear campaign.”

Trump Brokers Peace Deal Between DR Congo And Rwanda — Now Eyes Billions In US Investment

Trump brokers a peace deal between DR Congo and Rwanda, aiming to end conflict and unlock U.S. investment in critical African minerals.

The Unlikely Duo Rethinking Wearable Technology - Ad

Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.

RSV vaccine access expanded to some people in their 50s, according to CDC website

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following the advice of a recently fired panel of government vaccine advisers.

China lifts a nearly 2-year ban on seafood from Japan over Fukushima wastewater

BEIJING (AP) — China has to seafood from Japan after a nearly two-year ban over the discharge of slightly radioactive wastewater from the tsunami-destroyed Fukushima nuclear power plant.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

BigBear.ai, AMD, QuantumScape, Coinbase, Tesla: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks ended the day on a high note, with the Nasdaq gaining over 1.4% on Tuesday to 19,912.53. The Dow also traded up 1.2% to 43,089.02, while the S&P 500 rose by 1.1% to 6,092.18. These are the top stocks that gained the attention of retail traders and investors throughout the day:

No.1 Opportunity for 2025 [Take Action Now!] - Ad

Starlink's potential IPO Could Be the Biggest in History--Silicon Valley insider James Altucher has uncovered a way to profit BEFORE the IPO--with as little as $50. Musk's $180B giant is set to launch--will you miss out? Claim your spot before it's too late.

A hard-right lawmaker is sworn in as Greece's migration minister

ATHENS, Greece (AP) — A hard-right lawmaker was sworn in Monday as Greece’s migration minister, replacing a fellow right-wing political heavyweight who resigned following

Award-winning international correspondent launches a new journalism platform

NEW YORK (AP) — Jane Ferguson has won awards for unflinching reporting from dangerous lands including Afghanistan, Somalia and Yemen. So she was unlikely to be intimidated by seeking financing for a new journalism platform, despite tough times for the news industry.

A Historic Gold Announcement Is About to Rock Wall Street - Ad

The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.

US judge says China's Huawei Technologies must face criminal case for racketeering and other charges

BANGKOK (AP) — A U.S. judge has ruled that China’s Huawei Technologies, a leading telecoms equipment company, must face criminal charges in a wide reaching case alleging it stole technology and engaged in racketeering, wire and bank fraud and other crimes.

Cash-Rich IonQ To Capture 20% Of Quantum Market By 2035

IonQ shares climb as investors rally behind its bold quantum growth strategy and long-term market potential.

What It's Really Like To Work With Elon... - Ad

A business partner of mine recently told me how one morning, Elon's "DOGE Agents" simply showed up. The whole departments were merged. Dozens of tasks and contracts were reassigned. Several projects were permanently shut down and replaced. That's when he called me, and I realized what was happening.

In a blow to Milei, a US judge orders Argentina to turn over its majority stake in state oil company

BUENOS AIRES, Argentina (AP) — The fate of Argentina’s state-run oil company was thrown into doubt Monday as a U.S. judge ordered the cash-strapped country to give up its 51% controlling stake in YPF in partial compensation for seizing the shares of former investors during its 2012 nationalization of the energy group.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Iran's Top Diplomat To UN Says Uranium Enrichment To Continue: An 'Inalienable Right'

Iran reaffirms commitment to nuclear program despite US strikes. Ambassador cites Non-Proliferation Treaty as justification. Impact remains debated.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service